PKCι/λ was overexpressed in invasive prostate cancer tissue, and its inhibition significantly promoted apoptosis and reduced the proliferation of prostate cancer cells [168], although there are other conflicting reports related to prostate cancer growth and metastasis as well [151,156]. Here, PRKCA is linked to prostate carcinoma.